🔎 Trials Near Me

ホーム › 前立腺がん › アイダホ州

アイダホ州における前立腺がんの臨床試験

アイダホ州内の拠点で、前立腺がんに関する12件の研究が参加者を募集しています。

アイダホ州内の都市

公式研究テキスト(英語)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • 他9件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

  • Idaho Urologic Institute, Meridian
被験者募集中観察研究
40歳〜75歳 · 男性 · 2026/09/28更新 · NCT07543757

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Boise VA Medical Center, Boise, ID, Boise
被験者募集中第2相
18歳以上 · 男性 · 2026/09/17更新 · NCT04038502

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Saint Luke's Cancer Institute - Boise, Boise
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • Saint Luke's Cancer Institute - Fruitland, Fruitland
  • 他4件
被験者募集中第3相
18歳以上 · 男性 · 2026/08/19更新 · NCT04423211

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Saint Luke's Cancer Institute - Boise, Boise
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • Saint Luke's Cancer Institute - Fruitland, Fruitland
  • 他5件
被験者募集中第3相
18歳以上 · 男性 · 2026/07/14更新 · NCT06592924

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • 他10件
被験者募集中第2相
18歳以上 · 男性 · 2026/01/29更新 · NCT05806515

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • 他4件
被験者募集中第3相
18歳以上 · 男性 · 2026/01/22更新 · NCT06470243

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Boise
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls
被験者募集中第3相
18歳以上 · 男性 · 2025/09/11更新 · NCT03678025

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。